Of note, high expression of PRKN mRNA was found to be associated with improved survival of pancreatic cancer patients, whereas mRNA expression of PINK1 did not influence patient survival (22), indicating that PINK1 is a contributor of PDAC, but it is not a potential biomarker. The gene discussed is PINK1; the disease is pancreatic neoplasm.